Literature DB >> 6424168

Port Allegany Asbestos Health Program: a community response to a public health problem.

E C Holstein, K W Deuschle, S Bosch, E Fischer, A N Rohl, I J Selikoff.   

Abstract

The Port Allegany Asbestos Health Program (PAAHP) is a unique, community-run program that resulted from the successful cooperative efforts of a labor union, a corporation, community health care providers, and a medical school. PAAHP's goal is to develop a permanent community health organization that will use the most advanced existing knowledge to mitigate the adverse health effects anticipated as a result of the use of amosite asbestos in a Port Allegany, Pa. factory. All 1,188 persons employed by the factory during the years 1964-72 and the 3,000-4,000 persons in household contact with them are eligible for the program. PAAHP's major services are intensive medical surveillance, smoking cessation assistance, health education for participants, and continuing education for area physicians about asbestos-related diseases. One of the program's policies is not to disturb the usual patterns of medical care. If further testing or treatment is needed, patients are referred to their usual personal physicians. PAAHP does not provide ordinary medical care or medical insurance. Across the nation, the number of workers estimated to have been exposed to asbestos is more than 20 million, and their household contacts are estimated to be about three to four times that number. Adverse health effects resulting from asbestos exposure include elevated risk of lung cancer, mesothelioma, gastrointestinal tumors, and asbestosis. The problem requires the development of public health solutions. PAAHP has demonstrated the feasibility of a community-based model as one useful approach.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424168      PMCID: PMC1424537     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  18 in total

1.  CONCENTRATION OF CARCINOMA OR ATYPICAL CELLS IN SPUTUM.

Authors:  G SACCOMANNO; R P SAUNDERS; H ELLIS; V E ARCHER; B G WOOD; P A BECKLER
Journal:  Acta Cytol       Date:  1963 Sep-Oct       Impact factor: 2.319

2.  Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.

Authors:  J C WAGNER; C A SLEGGS; P MARCHAND
Journal:  Br J Ind Med       Date:  1960-10

3.  Mortality experience of insulation workers in the United States and Canada, 1943--1976.

Authors:  I J Selikoff; E C Hammond; H Seidman
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

4.  Expressed willingness of smokers to try 10 smoking withdrawal methods.

Authors:  J L Schwartz; M Dubitzky
Journal:  Public Health Rep       Date:  1967-10       Impact factor: 2.792

5.  Mesothelioma of pleura and peritoneum following exposure to asbestos in the London area.

Authors:  M L Newhouse; H Thompson
Journal:  Br J Ind Med       Date:  1965-10

6.  Insulation workers in Belfast. 3. Mortality 1940-66.

Authors:  P C Elmes; M J Simpson
Journal:  Br J Ind Med       Date:  1971-07

7.  Mayo Lung Project: evaluation of lung cancer screening through December 1979.

Authors:  L B Woolner; R S Fontana; D R Sanderson; W E Miller; J R Muhm; W F Taylor; M A Uhlenhopp
Journal:  Mayo Clin Proc       Date:  1981-09       Impact factor: 7.616

8.  Statistical comparison of aerosol-induced and spontaneous sputum specimens in the Tyler Asbestos Workers Program.

Authors:  J W McLarty; M L Farley; S D Greenberg; G A Hurst; L C Mabry
Journal:  Acta Cytol       Date:  1980 Sep-Oct       Impact factor: 2.319

9.  Comparison of sputum and lung asbestos body counts in former asbestos workers.

Authors:  V L Roggli; S D Greenberg; J W McLarty; G A Hurst; L R Hieger; M L Farley; L C Mabry
Journal:  Am Rev Respir Dis       Date:  1980-12

10.  The Tyler Asbestos Workers Program. I. A medical surveillance model and method.

Authors:  G A Hurst; C G Spivey; W T Matlage; J M Miller; G Faulk; L R Hieger; J W McLarty; S D Greenberg
Journal:  Arch Environ Health       Date:  1979 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.